Costamagna, Andrea
Pasquino, Chiara
Lamorte, Sara
Navarro-Tableros, Victor
Delsedime, Luisa
Fanelli, Vito
Camussi, Giovanni
Del Sorbo, Lorenzo https://orcid.org/0000-0003-3294-9838
Funding for this research was provided by:
Regione Piemonte
Università degli Studi di Torino
Article History
Received: 15 August 2024
Accepted: 26 November 2024
First Online: 3 December 2024
Declarations
:
: The experimental protocol (number 0253358) for this study was in accordance with the institutional animal welfare guidelines and approved by the Bioethical Committee of the University of Turin (approval date: 23/02/2012).
: Not applicable.
: The authors report the following disclosures: PC Ph.D. program—Doctoral School in Physiopathology Science at University of Turin; DSL Piemonte Regional Grant, CIHR: P-POD trial, AMO innovation fund SHS-UHN Toronto, ON Canada: IDENTIFY trial, CIHR: CORT-E2 trial, Biomarkers for detecting of outcome/risk of patients with a respiratory illness. Filing Date: 2021 Mar 15. Patents #: PCT/CA2021/050343, Canada as for attached COI disclosures. CG: Scientific coordinator for Unicyte AG.